Li Y - Search Results

1

A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice.

Liu XJ, Zheng YB, Li Y, Wu SY, Zhen YS. Liu XJ, et al. Among authors: li y. PLoS One. 2014 Dec 22;9(12):e115790. doi: 10.1371/journal.pone.0115790. eCollection 2014. PLoS One. 2014. PMID: 25531414 Free PMC article.

2

Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice.

Zhen YZ, Lin YJ, Li Y, Zhen YS. Zhen YZ, et al. Among authors: li y. Acta Pharmacol Sin. 2009 Jul;30(7):1025-32. doi: 10.1038/aps.2009.75. Acta Pharmacol Sin. 2009. PMID: 19575006 Free PMC article.

3

A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.

Zhong G, Zhang S, Li Y, Liu X, Gao R, Miao Q, Zhen Y. Zhong G, et al. Among authors: li y. Cancer Lett. 2010 Sep 1;295(1):124-33. doi: 10.1016/j.canlet.2010.02.020. Epub 2010 Mar 19. Cancer Lett. 2010. PMID: 20303650

4

Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.

Gong JH, Liu XJ, Li Y, Zhen YS. Gong JH, et al. Among authors: li y. Cancer Chemother Pharmacol. 2012 May;69(5):1323-32. doi: 10.1007/s00280-012-1827-9. Epub 2012 Feb 5. Cancer Chemother Pharmacol. 2012. PMID: 22311160

5

MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine.

Qin Y, Liu XJ, Li L, Liu XJ, Li Y, Gao RJ, Shao RG, Zhen YS. Qin Y, et al. Among authors: li y, li l. Oncol Rep. 2014 Jul;32(1):121-30. doi: 10.3892/or.2014.3169. Epub 2014 May 7. Oncol Rep. 2014. PMID: 24807584

6

Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.

Liu WJ, Liu XJ, Li L, Li Y, Zhang SH, Zhen YS. Liu WJ, et al. Among authors: li y, li l. Cancer Immunol Immunother. 2014 Dec;63(12):1261-72. doi: 10.1007/s00262-014-1604-1. Epub 2014 Aug 28. Cancer Immunol Immunother. 2014. PMID: 25164878 Free PMC article.

7

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy.

Xu J, Liu XJ, Li L, Zhang SH, Li Y, Gao RJ, Zhen YS. Xu J, et al. Among authors: li y, li l. Oncotarget. 2015 Sep 22;6(28):26322-34. doi: 10.18632/oncotarget.4709. Oncotarget. 2015. PMID: 26314845 Free PMC article.

8

Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice.

Zhu B, Shang B, Li Y, Zhen Y. Zhu B, et al. Among authors: li y. Mol Med Rep. 2016 May;13(5):4159-66. doi: 10.3892/mmr.2016.5041. Epub 2016 Mar 23. Mol Med Rep. 2016. PMID: 27035417 Free PMC article.

9

A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity.

Zheng YB, Gong JH, Liu XJ, Wu SY, Li Y, Xu XD, Shang BY, Zhou JM, Zhu ZL, Si SY, Zhen YS. Zheng YB, et al. Among authors: li y. Sci Rep. 2016 Aug 11;6:31472. doi: 10.1038/srep31472. Sci Rep. 2016. PMID: 27510727 Free PMC article.

10

A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.

Zheng YB, Gong JH, Liu XJ, Li Y, Zhen YS. Zheng YB, et al. Among authors: li y. Mol Carcinog. 2017 May;56(5):1395-1404. doi: 10.1002/mc.22600. Epub 2017 Jan 4. Mol Carcinog. 2017. PMID: 27991698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,199 results

Search Page

Filters